Avenue Therapeutics (ATXI) Proxy Filing summary

Executive summary

• Annual Meeting scheduled for December 30, 2025, to be held virtually, with voting on director elections and auditor ratification.

• Stockholders of record as of November 25, 2025, are eligible to vote; proxy materials are available online and by mail.

• Voting can be done online, by mobile device, or by mail, with revocation options available up to and during the meeting.

Voting matters and shareholder proposals

• Stockholders will vote to elect six directors for a one-year term and to ratify KPMG LLP as the independent auditor for 2025.

• Board recommends voting FOR all director nominees and FOR auditor ratification.

• Shareholder proposals for the 2026 meeting must be submitted by August 7, 2026, for inclusion in proxy materials.

Board of directors and corporate governance

• Board consists of six members, with a majority deemed independent under Nasdaq standards.

• Board committees include Audit and Compensation; no nominating committee, but independent directors oversee nominations.

• Directors are evaluated on experience, integrity, and commitment; diversity is considered informally.

• Board held five meetings in 2024, with all directors attending at least 75% of meetings.